# Lurasidone

## Latuda 40mg

| TAH Drug Code      | [OLAT](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OLAT)                                                                                                                                                                                                                                                                                                                   |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Schizophrenia in adults and adolescents (13 to 17 years old)                                                                                                                                                                                                                                                                                                                           |
| Dosing             | Should be taken with food (at least 350 kcal). Schizophrenia: 40mg QD. maximum: 160mg/day. Depressive episodes of type 1 bipolar disorder: 20mg QD， the dose can be increased based on clinical response after one week of treatment. maximum: 80mg/day.                                                                                                                              |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                               |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                               |
| Contraindications  | Hypersensitivity. Concomitant with strong CYP3A4 inhibitors (eg， ketoconazole， clarithromycin， ritonavir， voriconazole) & inducers (eg， rifampin， St. John's wort， phenytoin， carbamazepine).                                                                                                                                                                                  |
| Adverse Effects    | Akathisia， somnolence. Hypersensitivity; increased wt; insomnia， agitation， anxiety， restlessness; parkinsonism， dizziness， dystonia， dyskinesia; nausea， vomiting， dyspepsia， salivary hypersecretion， upper abdominal pain， stomach discomfort; rash， pruritus; musculoskeletal stiffness， increased blood creatine phoshokinase; increased serum creatinine; fatigue. |
| Pregnancy          | Human Data Suggest Risk in 3rd Trimester                                                                                                                                                                                                                                                                                                                                               |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                           |
| More Info          | [UpToDate](https://www.uptodate.com/contents/lurasidone-drug-information)                                                                                                                                                                                                                                                                                                              |

